MSA MSA Safety Inc
Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE · SEC CIK 66570 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY8.1%
TTM net income YoY8.2%
TTM EPS YoY9.7%
Revenue 3-yr CAGR5.1%
Net income 3-yr CAGR108.0%
Margins
Gross margin47.3%
Operating margin20.2%
Net margin15.0%
FCF margin16.0%
EBITDA margin24.1%
Returns
ROE22.1%
ROA10.4%
ROIC (approx.)14.9%
Asset turnover0.69x
Leverage & solvency
Liabilities / assets56.3%
Debt / equity0.78x
Current ratio2.65x
Interest coverage10.76x
Cash quality & payout
Operating cash flow / net income1.24x
Accruals ratio-2.5%
Payout ratio27.4%
Capex / revenue2.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $1.87B | $1.81B |
| Cost of revenue | $1.00B | $947.70M |
| Gross profit | $871.11M | $860.45M |
| R&D expense | $65.34M | $66.53M |
| SG&A expense | $414.25M | $394.71M |
| Operating income | $371.82M | $389.18M |
| Interest expense | $31.80M | $36.89M |
| Pretax income | $366.40M | $375.01M |
| Income tax | $87.47M | $90.04M |
| Net income | $278.92M | $284.97M |
| EBITDA | $443.41M | $453.51M |
| EPS (basic) | 7.11 | 7.24 |
| EPS (diluted) | 7.09 | 7.21 |
| Dividends declared per share | 2.10 | 2.00 |
| Weighted avg. shares (diluted) | 39.35M | 39.53M |
| Balance sheet | ||
| Cash & equivalents | $165.07M | $165.10M |
| Receivables | $306.45M | $279.21M |
| Inventory | $343.04M | $296.80M |
| Current assets | $869.29M | $803.03M |
| PP&E, net | $283.06M | $211.87M |
| Goodwill | $731.59M | $620.89M |
| Intangibles | $299.13M | $246.44M |
| Total assets | $2.55B | $2.21B |
| Current liabilities | $289.21M | $288.09M |
| Short-term debt | $8.22M | $26.39M |
| Long-term debt | $572.71M | $481.62M |
| Total debt | $580.93M | $508.01M |
| Total liabilities | $1.19B | $1.06B |
| Shareholders' equity | $1.37B | $1.14B |
| Net debt | $415.87M | $342.92M |
| Shares outstanding | 38.91M | 39.26M |
| Cash flow statement | ||
| Operating cash flow | $363.87M | $296.43M |
| Capital expenditure | $68.44M | $54.22M |
| Free cash flow | $295.43M | $242.21M |
| Investing cash flow | -$257.63M | -$53.76M |
| Financing cash flow | -$105.47M | -$208.69M |
| Depreciation & amortization | $71.59M | $64.33M |
| Stock-based compensation | $15.20M | $18.18M |
| Dividends paid | $82.34M | $78.76M |
Free plan shows the latest 2 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.